成人安非他酮治疗差错相关不良事件:美国四家毒物中心报告
该研究回顾性分析2004年1月1日至2016年12月31日美国四家毒物中心报告的成人急性、非故意、单种物质安非他酮治疗差错摄入病例,最终纳入637例。中位年龄42岁,76.1%为女性,56.2%在家庭管理;结局无效应50.1%、轻微45.5%、中度4.4%。无效应/轻微结局报告剂量694(±297)mg,中度结局1250(±815)mg(p < 0.0001);4例出现癫痫,中位发作时间7 h[范围2-21.5 h],中位报告剂量900 mg[范围600-3000 mg]。出现癫痫和/或院外不良事件者83%有「jittery」/焦虑/激越,无此类事件者27%(p = 0.008);12%报告心动过速/心悸,未报告更严重的心律失常。
要点
- 成人单次非故意安非他酮治疗差错摄入637例中,结局以无效应(50.1%)和轻微(45.5%)为主,中度4.4%。
- 无效应/轻微结局报告剂量694(±297)mg,中度结局1250(±815)mg(p < 0.0001),结局呈剂量相关。
- 4例发生癫痫,中位发作时间7 h[范围2-21.5 h],中位报告剂量900 mg[范围600-3000 mg]。
- 出现癫痫和/或院外不良事件者83%有「jittery」/焦虑/激越,无此类事件者27%(p = 0.008)。
- 12%报告心动过速/心悸,未报告更严重的心律失常。
适用人群与场景
- 成人、急性、非故意、单种物质安非他酮治疗差错摄入且结局已知,报告至四家美国毒物中心(2004年1月1日至2016年12月31日)。
红旗征与不能漏的情况
- 出现「jittery」/焦虑/激越:在发生癫痫和/或院外不良事件的患者中占83%,无此类事件者占27%(p = 0.008)。
- 癫痫:4例发生,中位发作时间7 h[范围2-21.5 h],中位报告剂量900 mg[范围600-3000 mg]。
- 心动过速/心悸:12%的病例报告,更严重的心律失常未报告。
研究设计与关键结果
- 回顾性研究,纳入637例符合标准的成人急性、非故意、单种物质安非他酮治疗差错摄入病例,数据来自四家美国毒物中心(2004年1月1日至2016年12月31日)。
- 中位年龄42岁,76.1%为女性,56.2%的病例在家庭管理。
- 结局:无效应50.1%,轻微45.5%,中度4.4%。
- 无效应/轻微结局报告剂量694(±297)mg,中度结局1250(±815)mg(p < 0.0001)。
- 癫痫4例,中位发作时间7 h[范围2-21.5 h],中位报告剂量900 mg[范围600-3000 mg]。
- 出现癫痫和/或院外不良事件者83%有「jittery」/焦虑/激越,无此类事件者27%(p = 0.008)。
- 12%的病例报告心动过速/心悸,更严重的心律失常未报告。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,成人单次非故意安非他酮摄入的结局总体轻微且呈剂量相关,在合适患者人群中剂量不超过900 mg时家庭管理可能是一个选择。
- 出现「jittery」/焦虑/激越可能提示癫痫和/或院外不良事件风险(83% vs 27%,p = 0.008)。
- 心动过速/心悸见于12%的病例,更严重的心律失常未报告。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: Bupropion is a frequently used medication. Excessive doses may cause altered mental status, seizures, and dysrhythmias. There is a need for accurate estimate of seizure risk with therapeutic errors and determination if minor symptoms are harbingers of more severe effects.
METHODS: A retrospective review of adult, acute, unintentional therapeutic error, single substance bupropion ingestions with known outcome reported to four poison centers from January 1, 2004 to December 31, 2016. Data included age, gender, single error dose, total bupropion dose over 18 h, prior history of seizure, management site, observation time, occurrence of an out-of-hospital adverse event, "jittery"/anxious/agitated, tachycardia/palpitations, seizures, and dysrhythmias. We recorded the total bupropion dose over 18 h if known; otherwise, we used the single error dose. We compared means for parametric data. We used Fisher's exact test and Mann-Whitney for nonparametric data.
RESULTS: We identified 754 potential cases, of which 637 met inclusion criteria after case review. Median age was 42 years, and 76.1% were female. Cases were predominantly managed at home (56.2%). Outcomes were no effect (50.1%), minor (45.5%) and moderate (4.4%). The reported dose with no effect/minor outcome was 694 (±297) mg, and for moderate outcome was 1250 (±815) mg (p < 0.0001). Seizures occurred in four patients with median onset time of 7 h [range 2-21.5 h]. The median reported dose in patients who seized was 900 mg [range 600-3000 mg]. Of patients who developed a seizure and/or an out-of-hospital adverse event, 83% were "jittery"/anxious/agitated whereas "jittery"/anxious/agitated was present in 27% of cases that did not (p = 0.008). Tachycardia/palpitations was reported in 12% of cases; more serious dysrhythmias were not reported.
CONCLUSIONS: Outcomes from single unintentional ingestions of bupropion in adults are overall mild and appear to be dose related. Home management may be an option with doses up to 900 mg in an appropriate patient population.
参考来源
- Beuhler MC, Spiller HA, Alwasiyah D, et al. Adverse effects associated with bupropion therapeutic errors in adults reported to four United States Poison Centers. Clin Toxicol (Phila). 2021. PMID: 34812101. doi:10.1080/15563650.2021.2002353
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。